Related Experiment Video
Updated: Jul 11, 2026

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model
Published on: April 18, 2015
Pancreas: patient body weight tailored contrast material injection protocol versus fixed dose protocol at dynamic CT
Yumi Yanaga1, Kazuo Awai, Yoshiharu Nakayama
1Department of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Kumamoto, Japan.
Purpose:
To prospectively compare the effect of a protocol with a fixed contrast material injection dose and one with a dose tailored to patient body weight on pancreatic enhancement at dynamic computed tomography (CT) of the pancreas.
Materials And Methods:
This study was approved by the institutional review board, and patients gave informed consent. Seventy-eight patients suspected of having pancreatic tumor were randomly assigned to one of two protocols (39 patients in each protocol). In protocol 1, a fixed contrast material dose (120 mL of iohexol 300) was delivered at an injection rate of 4.0 mL/sec; in protocol 2, a dose tailored to the patient's body weight (2.0 mL/kg) was injected over the course of 30 seconds. Scans were started 25, 45 (pancreatic parenchymal phase [PPP]), and 70 (portal venous phase [PVP]) seconds after the initiation of contrast material injection. Pancreatic enhancement during the PPP and hepatic enhancement during the PVP were compared by using the Student t test in patients whose body weight was less than 60 kg (group A) or 60 kg or greater (group B). A radiologist who was blinded to the injection protocol used measured the CT number of each organ.
Results:
With protocol 1, mean pancreatic enhancement during the PPP was 94.1 HU in group A and 76.1 HU in group B; the difference was statistically significant (P = .02). With protocol 2, mean pancreatic enhancement was 89.5 HU in group A and 84.7 HU in group B; there was no significant difference (P = .45). Mean hepatic enhancement with protocol 1 during the PVP was 59.6 HU in group A and 48.5 HU in group B (P < .01); with protocol 2, it was 55.4 HU in group A and 58.3 HU in group B. The difference was not statistically significant (P = .34).
Conclusion:
The dose protocol tailored to the patient's body weight yielded satisfactory pancreatic and hepatic enhancement irrespective of patient weight.
More Related Videos
Related Concept Videos
Radiological Investigation I: X-ray and CT
Imaging Studies for Cardiovascular System V: CT
Imaging Studies III: Computed Tomography
Imaging Studies I: CT and MRI
Description of the Procedures
Computed Tomography (CT) scan:
Computed Tomography (CT) scans use X-ray technology to generate detailed images of bones, organs, and tissues. During the scan, the patient lies on a moving table...
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Imaging Studies VII: Vascular Imaging

